Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Aspire Biopharma Holdings, Inc. - Common Stock
(NQ:
ASBP
)
0.5398
-0.6502 (-54.64%)
Streaming Delayed Price
Updated: 3:58 PM EDT, Apr 15, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Aspire Biopharma Holdings, Inc. - Common Stock
< Previous
1
2
3
4
5
6
Next >
12 Health Care Stocks Moving In Monday's After-Market Session
↗
May 19, 2025
Via
Benzinga
Top movers in Monday's after hours session
↗
May 19, 2025
Let's have a look at what is happening on the US markets after the closing bell on Monday. Below you can find the top gainers and losers in today's after hours session.
Via
Chartmill
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
May 14, 2025
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
↗
May 12, 2025
Via
Benzinga
Aspire Biopharma Holdings, Inc., to Present at Sidoti Virtual Investor Conference May 21
May 08, 2025
Via
ACCESS Newswire
12 Health Care Stocks Moving In Tuesday's After-Market Session
↗
April 29, 2025
Via
Benzinga
Aspire Biopharma Holdings, Inc., Announces Institutional Review Board Approval for In-Human Clinical Trial of an Oral Transmucosal Fast-Acting High-Dose Aspirin Formulation
April 29, 2025
Via
ACCESS Newswire
Aspire Biopharma Holdings, Inc., to Present at the Emerging Growth Conference on Thursday, April 17
April 14, 2025
Via
ACCESS Newswire
Aspire Biopharma Holdings, Inc., Commences Initial Production of its Pre-Workout Performance Supplement
April 11, 2025
Via
ACCESS Newswire
Aspire Biopharma Holdings, Inc., Announces Phase 1 Clinical Trial Initiation of its Oral Transmucosal Fast-Acting High-Dose Aspirin Formulation
April 09, 2025
Via
ACCESS Newswire
Aspire Biopharma Holdings, Inc., Contract Manufacturer, Glatt Air Techniques, Inc., has Completed Its First Good Manufacturing Practice (“GMP”) Clinical Batch of Pharmaceutical Grade Oral Mucosal Fast Acting Formulation of Aspirin
March 20, 2025
Via
ACCESS Newswire
Aspire Biopharma Holdings, Inc., Provides Update on Recently Filed U.S. Patent Applications for Its Sublingual Drug Delivery Platform
March 13, 2025
Via
ACCESS Newswire
Why Intel Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket
↗
March 13, 2025
Via
Benzinga
An Interview with the CEO: How Aspire Biopharma is Disrupting a $100 Billion Market with Sublingual Innovation
March 11, 2025
New York, New York--(Newsfile Corp. - March 11, 2025) - Aspire Biopharma Holdings, Inc. (NASDAQ: ASBP) ("Aspire" or the "Company")...
Via
Newsfile
Aspire Biopharma Holdings, Inc., to Launch the Next Generation of Pre-Workout Performance Supplement
March 03, 2025
Via
ACCESS Newswire
Aspire Biopharma Holdings, Inc., Provides an Update on Lead Product Candidate: High-Dose, Sublingual Aspirin
February 25, 2025
Via
ACCESS Newswire
Dow Tumbles Over 700 Points; US Services PMI Falls In February
↗
February 21, 2025
Via
Benzinga
Topics
Stocks
Aspire Biopharma Holdings, Inc. Announces the Execution of Securities Purchase Agreement
February 20, 2025
Via
ACCESS Newswire
< Previous
1
2
3
4
5
6
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
